Page last updated: 2024-08-22

cobaltous chloride and Squamous Cell Carcinoma of Head and Neck

cobaltous chloride has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adkins, DR; Kimple, RJ; Michel, LS; Nickel, KP; Redlich, N; Robinson, AM; Stein, AP; Uppaluri, R; Van Tine, BA; Wheeler, DL1

Other Studies

1 other study(ies) available for cobaltous chloride and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.
    Cell death & disease, 2018, 01-05, Volume: 9, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Cell Adhesion Molecules; Cell Line, Tumor; Cetuximab; Cobalt; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neuregulin-1; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-3; RNA Interference; RNA, Small Interfering; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous

2018